Drug Type Small molecule drug |
Synonyms 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole, NSC-721648, PMX-610 + [6] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H12FNO2S |
InChIKeyZRLSVQBGBBYEAZ-UHFFFAOYSA-N |
CAS Registry872726-44-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | United Kingdom | 12 Jan 2006 | |
Colonic Cancer | Preclinical | United Kingdom | 12 Jan 2006 | |
Lung Cancer | Preclinical | United Kingdom | 12 Jan 2006 |